bioRxivBioengineeringPreprint
Human heart assembloids with autologous tissue-resident macrophages recreate physiological immuno-cardiac interactions
Colin O’HerniD, Sammantha Caywood, Shakhlo AminovaiD, Artem M. KiseleviD, Brett D. VolmertiD, Fei WangiD, Merlinda-Loriane Sewavi, Weiheng Cao, Mia Dionise, Priyadharshni MuniyandiiD, Mirel Adrian PopaiD, Hussain F. Basrai, Milana Skoric, George Boulos, Amanda Huang, Isabel Nuñez-Regueiro, Nagib T. ChalfouniD, Sang‐Bum ParkiD, Nureddin A. AshammakhiiD, Chao ZhouiD, Christopher H. ContagiD, Aitor AguirreiD
Abstract
Interactions between the developing heart and the embryonic immune system are essential for proper cardiac development and maintaining homeostasis, with disruptions linked to various diseases. While human pluripotent stem cell (hPSC)-derived organoids are valuable models for studying human organ function, they often lack critical tissue-resident immune cells. Here, we introduce an advanced human heart assembloid model, termed hHMA (human heart-macrophage assembloid), which fully integrates autologous cardiac tissue- resident macrophages (MPs) with pre-existing human heart organoids (hHOs). Through multi-omic analyses, we confirmed that these MPs are phenotypically similar to embryonic cardiac tissue-resident MPs and remain viable in the assembloids over time. The inclusion of MPs significantly impacts hHMA development, influencing cardiac cellular composition, boosting cellular communication, remodeling the extracellular matrix, promoting ventricular morphogenesis, and enhancing sarcomeric maturation. Our findings indicate that MPs contribute to homeostasis via efferocytosis, integrate into the cardiomyocyte electrical system, and support catabolic metabolism. To demonstrate the versatility of this model, we developed a platform to study cardiac arrhythmias by chronic exposure to pro-inflammatory factors linked to arrhythmogenesis in clinical settings, successfully replicating key features of inflammasome-mediated atrial fibrillation. Overall, this work introduces a robust platform for examining the role of immune cells in cardiac development, disease mechanisms, and drug discovery, bridging the gap between in vitro models and human physiology. These findings offer insights into cardiogenesis and inflammation-driven heart disease, positioning the hHMA system as an invaluable tool for future cardiovascular research and therapeutic development.
- organism: human
- assay: scRNA-seq
- research focus: cell type annotation
- research focus: cell-cell communication
- research focus: development & morphogenesis
- research focus: differential expression
- approach: experimental assay
- Citations
- 10
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Tissue resident macrophages innately develop in a human iPSC-derived cardiac organoid model
Anna Rockel, Tobias Brunnbauer, … Philipp Wörsdörfer·bioRxiv·May 20, 2025
- Synergistic generation of cardiac resident-like macrophages and cardiomyocyte maturation in tissue engineered platforms
Meenakshi Suku, Jack F. Murphy, … Michael G. Monaghan·bioRxiv·Dec 4, 2024
- Modeling cardiac fibroblast heterogeneity from human pluripotent stem cell-derived epicardial cells
I. Fernandes, S. Funakoshi, … G. Keller·bioRxiv·Oct 22, 2023
- Generation and Maturation of Human iPSC-derived Cardiac Organoids in Long Term Culture
E. Ergir, J. Oliver-de la Cruz, … G. Forte·bioRxiv·Mar 7, 2022
- Development of a human heart-on-a-chip model using induced pluripotent stem cells, fibroblasts and endothelial cells
Y. Liu, R. Kamran, … K. Takahashi·bioRxiv·Dec 6, 2023
- GENERATION OF HEART ORGANOIDS MODELING EARLY HUMAN CARDIAC DEVELOPMENT UNDER DEFINED CONDITIONS
Y. Israeli, M. Gabalski, … A. Aguirre·bioRxiv·Jun 25, 2020